Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Feb 17, 2026
Reporting period
Not applicable
Filed with the SEC
Feb 20, 2026
OfficerGrant / award
Context
Classification
grant award
Code A — grant or award
Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0000105770-26-000019
Filed / recorded
Feb 20, 2026, 12:04 AM UTC
Added to OQRO
Oct 2, 2026, 12:29 PM UTC
Parser
form4-xml-v1
Data quality
Verified: identifiers matched exactly
Issuer
WEST PHARMACEUTICAL SERVICES INC
Issuer CIK
105770
Ticker
WST
Reporting person
Charles Witherspoon
Relationship
Officer
Officer title
VP & Treasurer
Security
Common Stock
Table
Non-derivative (Table I)
Transaction date
Feb 17, 2026
Transaction code
A
Shares / units
115.91
Price per share
$0.00
Acquired / disposed
Acquired (A)
Shares owned after
1,411.265
Ownership form
Direct
Amendment
No
Footnotes from the filing
These shares result from performance stock units (PSUs) which vested at the end of the respective 2023-2025 PSU performance period and were payable on the transaction date shown.